X-11758742-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_078629.4(MSL3):c.102+377C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,165,592 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000025 ( 0 hom. 5 hem. )
Consequence
MSL3
NM_078629.4 intron
NM_078629.4 intron
Scores
12
Clinical Significance
Conservation
PhyloP100: -0.0210
Genes affected
MSL3 (HGNC:7370): (MSL complex subunit 3) This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant X-11758742-C-T is Benign according to our data. Variant chrX-11758742-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3211693.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSL3 | NM_078629.4 | c.102+377C>T | intron_variant | ENST00000312196.10 | |||
MSL3 | NM_001193270.2 | c.35C>T | p.Ala12Val | missense_variant | 1/13 | ||
MSL3 | NM_001282174.1 | c.-263+377C>T | intron_variant | ||||
MSL3 | NM_078628.2 | c.102+377C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSL3 | ENST00000312196.10 | c.102+377C>T | intron_variant | 1 | NM_078629.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000187 AC: 21AN: 112402Hom.: 0 Cov.: 23 AF XY: 0.000174 AC XY: 6AN XY: 34558
GnomAD3 genomes
AF:
AC:
21
AN:
112402
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
34558
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000277 AC: 3AN: 108185Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 39395
GnomAD3 exomes
AF:
AC:
3
AN:
108185
Hom.:
AF XY:
AC XY:
0
AN XY:
39395
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000247 AC: 26AN: 1053136Hom.: 0 Cov.: 31 AF XY: 0.0000145 AC XY: 5AN XY: 344540
GnomAD4 exome
AF:
AC:
26
AN:
1053136
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
344540
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000187 AC: 21AN: 112456Hom.: 0 Cov.: 23 AF XY: 0.000173 AC XY: 6AN XY: 34622
GnomAD4 genome
AF:
AC:
21
AN:
112456
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
34622
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N;N
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Vest4
MutPred
Loss of disorder (P = 0.0875);Loss of disorder (P = 0.0875);
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -6
Find out detailed SpliceAI scores and Pangolin per-transcript scores at